Así lo indica el último estudio de Nutrimedia, el proyecto de la UPF y el Centro Cochrane Iberoamérica para evaluar la veracidad de los mensajes sobre alimentación y salud difundidos por medios de...
Read moreEl estudio servirá de base a dos ensayos internacionales para comprobar la eficacia del fármaco Azeliragon en estos tumores cerebrales agresivos
Read moreNow, a study led by the University of Barcelona confirms the therapeutic efficiency of a new compound against psoriasis, which could avoid the risks associated with previously known therapies. The stu...
Read moreUn equipo investigador de la URV participa en un proyecto, en colaboración con el Centro de Investigación Tecnológica del País Vasco y Costa Concentrados Levantinos, para formular una bebida funci...
Read moreThe latest call for independent research project grants from the Carlos III Health Institute has selected three projects led by researchers from the Hospital del Mar Research Institute. These projects...
Read moreEleva provides 3PBIOVIAN with access to its proprietary moss-based expression system to build-up manufacturing capacity for future partnered projects
Read moreEl Instituto de Neurociencias de Castilla y León (INCYL) trabaja en una línea de investigación contra el glioblastoma y ha logrado resultados prometedores
Read moreBiotechnology has radically changed the treatment of many types of tumors, evolving from highly aggressive and non-specific treatments to those tailored to the unique characteristics of each patient. ...
Read moreMineralys Therapeutics today announced that it has completed enrollment in the Explore-CKD Phase 2 trial evaluating the efficacy and safety of lorundrostat for the treatment of hypertension in subject...
Read moreResearchers from Hospital Clínic-IDIBAPS and the CIBER Hepatic and Digestive Diseases (CIBEREHD) have led a European study to evaluate the efficacy of a new treatment with simvastatin and rifaximin i...
Read moreLas terapias biológicas anti-factor de necrosis tumoral (TNF) han supuesto un antes y un después en el tratamiento de la enfermedad inflamatoria intestinal (EII), permitiendo a muchos pacientes mant...
Read morePublished in the journal Nature Communications*, results from a first-in-human, phase I clinical trial of an oral, potent and reversible inhibitor of methionine adenosyltransferase 2 A (MT2A)—a key ...
Read more